Law 360 M&A

NOVEMBER 16, 2023

Two pension fund stockholders of animal health company Covetrus Inc. have sued the company's CEO and directors in Delaware's Court of Chancery, alleging that private equity firm and major shareholder Clayton Dubilier & Rice LLC was given unfair advantages when it bought Covetrus in a $21-per-share takeover with TPG Capital.

Private Equity Firm 40

Private Equity Firm Equity 40

Law 360 M&A

NOVEMBER 20, 2023

New cases involved Walt Disney, Real Life, Zendesk and animal health company Covetrus Inc. Lawsuits that went nowhere got pretty expensive in Delaware's Court of Chancery last week, which saw the award of a multimillion-dollar "mootness" fee and a settlement of litigation that closed a $720 million deal.

40

40

Benzinga

MAY 25, 2022

Clayton, Dubilier & Rice (CD&R), a private investment firm, and TPG Capital will acquire animal-health technology and services company Covetrus Inc (NASDAQ: CVET ) for $21.00 CD&R and its affiliates currently beneficially own approximately 24% of the company's outstanding shares of common stock.

Enterprise Value 52

Enterprise Value Technology 52

Benzinga

MAY 23, 2022

Raymond James downgraded the rating on Covetrus Inc (NASDAQ: CVET ) from Outperform to Market Perform and removed the prior $22 price target after the company received a buyout at $21 per share. Though $21 may not ultimately prove to be the final resting place in terms of the offer price.

Marketability 59

Marketability 59

Law 360 M&A

OCTOBER 14, 2022

Two union pension funds and a hedge fund have jointly sued animal health technology company Covetrus Inc. in Delaware for records on the company's newly closed, $4 billion take-private sale, saying the deal price appears too low and could have violated takeover restrictions.

Technology 40

Technology 40